CN108355185A - Automation equipment and storage medium for monitoring concentration of glucose in dialyzate - Google Patents
Automation equipment and storage medium for monitoring concentration of glucose in dialyzate Download PDFInfo
- Publication number
- CN108355185A CN108355185A CN201810193947.7A CN201810193947A CN108355185A CN 108355185 A CN108355185 A CN 108355185A CN 201810193947 A CN201810193947 A CN 201810193947A CN 108355185 A CN108355185 A CN 108355185A
- Authority
- CN
- China
- Prior art keywords
- dialyzate
- glucose
- concentration
- thresholding
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Abstract
The present invention provides a kind of automation equipment for monitoring concentration of glucose in dialyzate, device includes：Detection module, monitoring modular be used to detect the percentage of time C of 24 hourly average blood glucose level A, 24 hours blood glucose level standard deviation B, blood glucose fluctuation in some range of dialysis patient, blood glucose fluctuation in a certain range area under the curve D, average blood glucose fluctuation range E and in a few days maximum blood glucose fluctuation amplitude F；Computing module, computing module are used to, based on A, B, C, D, E and F value monitored, calculate concentration of glucose control parameter P in dialyzate；Decision-making module, decision-making module are used to, based on concentration of glucose parameter P in dialyzate, determine concentration of glucose situation in dialyzate；Sending module, sending module are used to concentration of glucose situation in dialyzate being sent to user terminal.The device of the invention is focused on distinguishing patient class, and it is that patient provides unnecessary glucose to prevent blindness.The present invention scientifically determines the sugared content of dialyzate, avoids generating damage for patient.
Description
Technical field
The present invention relates to dialyzates to monitor field, more particularly to is used to monitor the automatic makeup of concentration of glucose in dialyzate
It sets and storage medium.
Background technology
The dialysis patient of diabetic nephropathy than other dialysis patients be easier occur dialysis hypoglycemia (hypoglycemia,
HG) and low blood pressure (hypotension, HP), there is certain relationship between the two, hypoglycemia occurs often with the hair of low blood pressure
It is raw, and increase with the diabetic nephropathy dialysis patient death rate related.It is existing studies have shown that occur HG the reason of be：Use sugar-free
Dialysis treatment can cause to lose glucose；Carbon dioxide level, which increases, in dialyzate makes intracellular anaerobic metabolism enhance, grape
The consumption of sugar obviously increases；When kidney failure, kidney is impaired to the inactivation capacity of insulin, and the insulin receptor after dialysis
Increased activity makes body enhance the reactivity of insulin；Kidney failure makes that the degradation of exogenous insulin is reduced, half-life period prolongs
It is long, and insulin is macromolecular substances, can not be removed by haemodialysis；Angiotensin converting enzyme inhibitor.
The research of the prior art also shows：After suitable glucose is added in dialyzate, dialyzate can be at least reduced
Sugar is lost, and in hypoglycemia, sugar in dialyzate makes the hypoglycemia of dialysis procedure send out it is also possible to shifted into blood
Raw rate significantly reduces.The research recognizes simultaneously：Although blood glucose rise during diabetic being made to dialyse containing sugared dialyzate, its
Reduce the number and frequency of hypoglycemia generation.
Being disclosed in the information of the background technology part, it is only intended to increase understanding of the overall background of the invention, without answering
It has been the prior art well known to persons skilled in the art when being considered as recognizing or imply that the information is constituted in any form.
Invention content
The purpose of the present invention is to provide a kind of for monitoring the automation equipment of concentration of glucose and storage in dialyzate
Medium, to overcome the following disadvantage of the prior art：All diabetes dialysis patients are all made of with the mode of dialyzate sugaring
Treated, it is inadequate for the discrimination of patient, cause it is certain be not in low sugar disease mild diabetes patient or special
Diabetic also receives unnecessary sugar.There is no a kind of sugared content of science to determine method, in dialyzate sugared ingredient for
The safety of patient is most important, but currently available technology does not propose how the determination dialyzate sugared content of science, at present
Clinically generally sugared content is determined using " trial-and-error method ", this damage for patient is very big.
The present invention provides a kind of automation equipments for monitoring concentration of glucose in dialyzate, it is characterised in that：Dress
Set including：Detection module, monitoring modular are used to detect 24 hourly average blood glucose level A of dialysis patient, 24 hours blood glucose levels
Standard deviation B, blood glucose fluctuation are in the percentage of time C of some range, blood glucose fluctuation in a certain range area under the curve D, average blood
Sugared fluctuating range E and in a few days maximum blood glucose fluctuation amplitude F；Computing module, computing module be used for based on monitored A, B, C,
D, E and F values calculate concentration of glucose control parameter P in dialyzate；Decision-making module, decision-making module are used for based in dialyzate
Concentration of glucose parameter P, determines concentration of glucose situation in dialyzate；Sending module, sending module are used for Portugal in dialyzate
Grape sugar concentration profile is sent to user terminal.
Preferably, in above-mentioned technical proposal, wherein based on A, B, C, D, E and F value monitored, calculate in dialyzate
Concentration of glucose control parameter P is specially：Based on following formula, concentration of glucose control parameter P in dialyzate is calculated：
Wherein, t indicates detection time.
Preferably, in above-mentioned technical proposal, based on concentration of glucose parameter P in dialyzate, glucose in dialyzate is determined
Concentration profile is specially：When P values are more than the first thresholding, determine that concentration of glucose should be more than the first numerical value in dialyzate；Work as P
When value is less than the first thresholding and more than the second thresholding, determine in dialyzate that concentration of glucose should be more than second value and less than the
One numerical value；When P values are less than the second thresholding and are more than third thresholding, determine that concentration of glucose should be more than third number in dialyzate
It is worth and is less than second value；When P values are less than third thresholding, determine and be free of glucose in dialyzate.
Preferably, in above-mentioned technical proposal, automation equipment further includes：Threshold value intelligence determining module, threshold value intelligence
Determining module be used for by it is following operation come determine the first thresholding, the second thresholding, third thresholding, the first numerical value, second value with
And third value：Collect the historical clinical letter of dialysis machine brand message, dialyzate brand message and hospital where dialysis patient
Breath；Based on the historical clinical information for collecting dialysis machine brand message, dialyzate brand message and dialysis patient place hospital, profit
The first thresholding, the second thresholding, third thresholding, the first numerical value, second value and third value are determined with neural network algorithm.
The present invention also provides a kind of non-transitory storage medium for monitoring concentration of glucose in dialyzate, features
It is：Non-transitory storage medium includes instruction, and instruction is for performing the following operations：Detect 24 hourly average blood of dialysis patient
Sugar level A, 24 hours blood glucose level standard deviation B, blood glucose fluctuation are in the percentage of time C of some range, blood glucose fluctuation in a certain
Range area under the curve D, average blood glucose fluctuation range E and in a few days maximum blood glucose fluctuation amplitude F；Based on monitored A, B, C,
D, E and F values calculate concentration of glucose control parameter P in dialyzate；Based on concentration of glucose parameter P in dialyzate, determine saturating
Analyse concentration of glucose situation in liquid；Concentration of glucose situation in dialyzate is sent to user terminal.
Preferably, in above-mentioned technical proposal, based on A, B, C, D, E and F value monitored, glucose in dialyzate is calculated
Concentration control parameter P is specially：Based on following formula, concentration of glucose control parameter P in dialyzate is calculated：
Wherein, t indicates detection time.
Preferably, in above-mentioned technical proposal, based on concentration of glucose parameter P in dialyzate, glucose in dialyzate is determined
Concentration profile is specially：When P values are more than the first thresholding, determine that concentration of glucose should be more than the first numerical value in dialyzate；Work as P
When value is less than the first thresholding and more than the second thresholding, determine in dialyzate that concentration of glucose should be more than second value and less than the
One numerical value；When P values are less than the second thresholding and are more than third thresholding, determine that concentration of glucose should be more than third number in dialyzate
It is worth and is less than second value；When P values are less than third thresholding, determine and be free of glucose in dialyzate.
Preferably, in above-mentioned technical proposal, non-transitory storage medium further includes instructions for performing the following operations：It is logical
Following operation is crossed to determine the first thresholding, the second thresholding, third thresholding, the first numerical value, second value and third value：It collects
The historical clinical information of dialysis machine brand message, dialyzate brand message and hospital where dialysis patient；It is dialysed based on collecting
The historical clinical information of machine brand message, dialyzate brand message and hospital where dialysis patient, utilizes neural network algorithm
To determine the first thresholding, the second thresholding, third thresholding, the first numerical value, second value and third value.
Compared with prior art, the present invention has the advantages that：Complete detection 24 hourly averages of dialysis patient
Percentage of time C, the blood glucose fluctuation Mr. Yu of blood glucose level A, 24 hours blood glucose level standard deviation B, blood glucose fluctuation in some range
One range area under the curve D, average blood glucose fluctuation range E and in a few days maximum blood glucose fluctuation amplitude F, can based on these data
One very accurately assessment is generated to patient's concrete condition, the concrete type of diabetes mellitus can be distinguished, be then directed to
The amount of the parameter value adjustment dialyzate sugaring of each patient and whether sugaring, the device of the invention focuses on distinguishing patient class,
Be not in it is certain be not in low sugar disease mild diabetes patient or special diabetic unnecessary sugar is provided
Situation.Present invention uses neural network and big data methods, the sugared content of dialyzate are scientifically determined, avoiding makes
The trial that sugared content is carried out with trial-and-error method avoids generating damage for patient.
Description of the drawings
Fig. 1 is the method flow diagram according to an embodiment of the invention for monitoring concentration of glucose in dialyzate.
Specific implementation mode
Unless otherwise explicitly stated, otherwise in entire disclosure and claims, term " comprising " or its change
It changes such as "comprising" or " including " etc. and will be understood to comprise stated element or component, and do not exclude other members
Part or other component parts.
Fig. 1 is the method flow diagram according to an embodiment of the invention for monitoring concentration of glucose in dialyzate.Such as Fig. 1
It is shown, the method for the present invention includes：Step 101：Detect 24 hourly average blood glucose level A, the 24 hours blood glucose water of dialysis patient
Flat standard deviation B, blood glucose fluctuation are in the percentage of time C of some range, blood glucose fluctuation in a certain range area under the curve D, average
Blood glucose fluctuation amplitude E and in a few days maximum blood glucose fluctuation amplitude F；Step 102：Based on A, B, C, D, E and F value monitored,
Calculate concentration of glucose control parameter P in dialyzate；Step 103：Based on concentration of glucose parameter P in dialyzate, dialysis is determined
Concentration of glucose situation in liquid；Step 104：Concentration of glucose situation in dialyzate is sent to user terminal.Wherein, it is based on institute
A, B, C, D, E and F value of monitoring, calculating concentration of glucose control parameter P in dialyzate is specially：Based on following formula, meter
Calculate concentration of glucose control parameter P in dialyzate：
Wherein, t indicates detection time.
Based on concentration of glucose parameter P in dialyzate, determine that concentration of glucose situation is specially in dialyzate：When P values are big
When the first thresholding, determine that concentration of glucose should be more than the first numerical value in dialyzate；When P values are less than the first thresholding and more than the
When two thresholdings, determine that concentration of glucose should be more than second value and be less than the first numerical value in dialyzate；When P values are less than second
When limiting and being more than third thresholding, determine that concentration of glucose should be more than third value and be less than second value in dialyzate；When P values
When less than third thresholding, determines and be free of glucose in dialyzate.Non-transitory storage medium further includes for performing the following operations
Instruction：The first thresholding, the second thresholding, third thresholding, the first numerical value, second value and third are determined by following operation
Numerical value：Collect the historical clinical information of dialysis machine brand message, dialyzate brand message and hospital where dialysis patient；It is based on
The historical clinical information for collecting dialysis machine brand message, dialyzate brand message and hospital where dialysis patient, utilizes nerve
Network algorithm determines the first thresholding, the second thresholding, third thresholding, the first numerical value, second value and third value.The present invention
Complete detection 24 hourly average blood glucose level A of dialysis patient, 24 hours blood glucose level standard deviation B, blood glucose fluctuations are in some
Percentage of time C, the blood glucose fluctuation of range are maximum in a certain range area under the curve D, average blood glucose fluctuation range E and in a few days
Blood glucose fluctuation amplitude F can generate patient's concrete condition one very accurately assessment based on these data, can distinguish
The concrete type of diabetes mellitus, then be directed to each patient parameter value adjustment dialyzate sugaring amount and whether sugaring,
The device of the invention focus on distinguish patient class, be not in it is certain be not in low sugar disease mild diabetes patient or
Special diabetic provides the situation of unnecessary sugar.Present invention uses neural network and big data methods, scientifically
The sugared content that dialyzate is determined avoids the trial that sugared content is carried out using trial-and-error method, avoids generating damage for patient.
In the present invention, the programmed method of neural network algorithm itself is well known to those skilled in the art；User terminal can be doctor
The either mobile phone of nurse or tablet device etc. can be connected between user terminal and the device of the invention by Radio Link.
The present invention also provides a kind of automation equipment of concentration of glucose in monitoring dialyzate, device includes：Detect mould
Block, monitoring modular are used to detect 24 hourly average blood glucose level A, 24 hours blood glucose level standard deviation B, the blood glucose waves of dialysis patient
Move the percentage of time C in some range, blood glucose fluctuation in a certain range area under the curve D, average blood glucose fluctuation range E and
In a few days maximum blood glucose fluctuation amplitude F；Computing module, computing module are used to, based on A, B, C, D, E and F value monitored, calculate
Concentration of glucose control parameter P in dialyzate；Decision-making module, decision-making module are used for based on concentration of glucose parameter P in dialyzate,
Determine concentration of glucose situation in dialyzate；Sending module, sending module is for sending concentration of glucose situation in dialyzate
To user terminal.Wherein, based on A, B, C, D, E and F value monitored, concentration of glucose control parameter P in dialyzate is calculated
Specially：Based on following formula, concentration of glucose control parameter P in dialyzate is calculated：
Wherein, t indicates detection time.
Based on concentration of glucose parameter P in dialyzate, determine that concentration of glucose situation is specially in dialyzate：When P values are big
When the first thresholding, determine that concentration of glucose should be more than the first numerical value in dialyzate；When P values are less than the first thresholding and more than the
When two thresholdings, determine that concentration of glucose should be more than second value and be less than the first numerical value in dialyzate；When P values are less than second
When limiting and being more than third thresholding, determine that concentration of glucose should be more than third value and be less than second value in dialyzate；When P values
When less than third thresholding, determines and be free of glucose in dialyzate.Automation equipment further includes：Threshold value intelligence determining module, door
Limit value intelligence determining module is used to determine the first thresholding, the second thresholding, third thresholding, the first numerical value, the by following operation
Two numerical value and third value：Collect going through for dialysis machine brand message, dialyzate brand message and hospital where dialysis patient
History clinical information；Faced based on the history for collecting dialysis machine brand message, dialyzate brand message and dialysis patient place hospital
Bed information, using neural network algorithm come determine the first thresholding, the second thresholding, third thresholding, the first numerical value, second value and
Third value.
It is non-provisional the present invention also provides a kind of non-transitory storage medium for monitoring concentration of glucose in dialyzate
Property storage medium include instruction, instruction for performing the following operations：24 hourly average blood glucose level A of detection dialysis patient, 24
Hour blood glucose level standard deviation B, blood glucose fluctuation are in the percentage of time C of some range, blood glucose fluctuation under a certain range curve
Area D, average blood glucose fluctuation range E and in a few days maximum blood glucose fluctuation amplitude F；Based on A, B, C, D, E and the F monitored
Value calculates concentration of glucose control parameter P in dialyzate；Based on concentration of glucose parameter P in dialyzate, Portugal in dialyzate is determined
Grape sugar concentration profile；Concentration of glucose situation in dialyzate is sent to user terminal.Based on A, B, C, D, the E monitored and
F values, calculating concentration of glucose control parameter P in dialyzate is specially：Based on following formula, concentration of glucose in dialyzate is calculated
Control parameter P：
Wherein, t indicates detection time.
Based on concentration of glucose parameter P in dialyzate, determine that concentration of glucose situation is specially in dialyzate：When P values are big
When the first thresholding, determine that concentration of glucose should be more than the first numerical value in dialyzate；When P values are less than the first thresholding and more than the
When two thresholdings, determine that concentration of glucose should be more than second value and be less than the first numerical value in dialyzate；When P values are less than second
When limiting and being more than third thresholding, determine that concentration of glucose should be more than third value and be less than second value in dialyzate；When P values
When less than third thresholding, determines and be free of glucose in dialyzate.
Non-transitory storage medium further includes instructions for performing the following operations：First is determined by following operation
Limit, the second thresholding, third thresholding, the first numerical value, second value and third value：Collect dialysis machine brand message, dialyzate
The historical clinical information of hospital where brand message and dialysis patient；Based on collection dialysis machine brand message, dialyzate brand
The historical clinical information of hospital where information and dialysis patient, using neural network algorithm come determine the first thresholding, second
Limit, third thresholding, the first numerical value, second value and third value.
By the various elements including block, module, component, circuit, step, process, algorithm etc. in specific embodiment party
It is described in formula and device and method is shown in the accompanying drawings.Electronic hardware, computer software or its any group can be used
It closes and comes individually or realize these elements or its any part in combination with other elements and/or function.These elements are implemented as
The design constraint that hardware or software depend on specific application and applies to whole system.In one aspect, as made herein
Term " component " can be one of component of composition system and can be divided into other assemblies.
For example, any portion of element or element can be realized with " system " including one or more processors
Point or element arbitrary combination.Processor may include general processor, digital signal processor (DSP), special integrated electricity
It is road (ASIC), field programmable gate array (FPGA) or other programmable logic components, discrete gate or transistor logic, discrete hard
Part component, or any combination thereof, or be designed as executing any other suitable component of function described herein.General processor
Can be microprocessor, but alternatively, processor can be any traditional processor, controller, microcontroller or shape
State machine.Processor is also implemented as the combination of computation module, for example, the combination of DSP and microprocessor, multi-microprocessor,
One or more microprocessors combination DSP or any other such configuration.
One or more of system processor can execute software.Software should be broadly interpreted as indicating instruction, refer to
Enable collection, code, code segment, program code, program, subprogram, software module, application program, software application, software package,
Routine, subroutine, object, executable program, the thread of execution, process, function etc., no matter be known as software, firmware, in
Between part, microcode, hardware description language or other.The software may reside within temporary or non-transitory computer-readable medium
On.As an example, non-transitory computer-readable medium may include magnetic storage facilities (for example, hard disk, floppy disk, magnetic stripe), light
Disk (for example, compact disk (CD), digital versatile disc (DVD)), smart card, flash memory device (for example, card, stick, key drive), with
Machine accesses memory (RAM), static state RAM (SRAM), dynamic ram (DRAM), synchronous dynamic ram (SDRAM)；Double Data Rate
RAM (DDRAM), read-only memory (ROM), programming ROM (PROM), erasable PROM (EPROM), electric erasable PROM
(EEPROM), general register or any other suitable non-state medium for storing software.
The description of the aforementioned specific exemplary embodiment to the present invention is in order to illustrate and illustration purpose.These descriptions
It is not wishing to limit the invention to disclosed precise forms, and it will be apparent that according to the above instruction, can much be changed
And variation.The purpose of selecting and describing the exemplary embodiment is that explaining the specific principle of the present invention and its actually answering
With so that those skilled in the art can realize and utilize the present invention a variety of different exemplary implementation schemes and
Various chooses and changes.The scope of the present invention is intended to be limited by claims and its equivalents.
Claims (8)
1. a kind of automation equipment for monitoring concentration of glucose in dialyzate, it is characterised in that：Described device includes：
Detection module, the monitoring modular are used to detect 24 hourly average blood glucose level A of dialysis patient, 24 hours blood glucose levels
Standard deviation B, blood glucose fluctuation are in the percentage of time C of some range, blood glucose fluctuation in a certain range area under the curve D, average blood
Sugared fluctuating range E and in a few days maximum blood glucose fluctuation amplitude F；
Computing module, the computing module are used to, based on A, B, C, D, E and F value monitored, calculate glucose in dialyzate
Concentration control parameter P；
Decision-making module, the decision-making module are used to, based on concentration of glucose parameter P in the dialyzate, determine grape in dialyzate
Sugared concentration profile；
Sending module, the sending module are used to concentration of glucose situation in the dialyzate being sent to user terminal.
2. automation equipment as described in claim 1, it is characterised in that：Wherein, based on A, B, C, D, E and the F monitored
Value, calculating concentration of glucose control parameter P in dialyzate is specially：
Based on following formula, concentration of glucose control parameter P in dialyzate is calculated：
Wherein, t indicates detection time.
3. automation equipment as described in claim 1, it is characterised in that：Based on concentration of glucose parameter P in the dialyzate,
Determine that concentration of glucose situation is specially in dialyzate：
When the P values are more than the first thresholding, determine that concentration of glucose should be more than the first numerical value in dialyzate；
When the P values are less than the first thresholding and are more than the second thresholding, determine that concentration of glucose should be more than second in dialyzate
Numerical value and be less than the first numerical value；
When the P values are less than the second thresholding and are more than third thresholding, determine that concentration of glucose should be more than third in dialyzate
Numerical value and be less than second value；
When the P values are less than third thresholding, determine and be free of glucose in dialyzate.
4. automation equipment as claimed in claim 3, it is characterised in that：The automation equipment further includes：
Threshold value intelligence determining module, the threshold value intelligence determining module be used for by it is following operation come determine the first thresholding,
Second thresholding, third thresholding, the first numerical value, second value and third value：
Collect the historical clinical information of dialysis machine brand message, dialyzate brand message and hospital where dialysis patient；
Historical clinical letter based on hospital where the collection dialysis machine brand message, dialyzate brand message and dialysis patient
Breath, determined using neural network algorithm first thresholding, the second thresholding, third thresholding, the first numerical value, second value and
Third value.
5. a kind of non-transitory storage medium for monitoring concentration of glucose in dialyzate, it is characterised in that：It is described non-provisional
Property storage medium include instruction, described instruction is for performing the following operations：
24 hourly average blood glucose level A of dialysis patient, 24 hours blood glucose level standard deviation B, blood glucose fluctuations are detected in some model
The percentage of time C that encloses, the blood glucose fluctuation maximum blood in a certain range area under the curve D, average blood glucose fluctuation range E and in a few days
Sugared fluctuating range F；
Based on A, B, C, D, E and F value monitored, concentration of glucose control parameter P in dialyzate is calculated；
Based on concentration of glucose parameter P in the dialyzate, concentration of glucose situation in dialyzate is determined；
Concentration of glucose situation in the dialyzate is sent to user terminal.
6. non-transitory storage medium as claimed in claim 5, it is characterised in that：Based on A, B, C, D, E and the F monitored
Value, calculating concentration of glucose control parameter P in dialyzate is specially：
Based on following formula, concentration of glucose control parameter P in dialyzate is calculated：
Wherein, t indicates detection time.
7. non-transitory storage medium as claimed in claim 5, it is characterised in that：Based on concentration of glucose in the dialyzate
Parameter P determines that concentration of glucose situation is specially in dialyzate：
When the P values are more than the first thresholding, determine that concentration of glucose should be more than the first numerical value in dialyzate；
When the P values are less than the first thresholding and are more than the second thresholding, determine that concentration of glucose should be more than second in dialyzate
Numerical value and be less than the first numerical value；
When the P values are less than the second thresholding and are more than third thresholding, determine that concentration of glucose should be more than third in dialyzate
Numerical value and be less than second value；
When the P values are less than third thresholding, determine and be free of glucose in dialyzate.
8. non-transitory storage medium as claimed in claim 7, it is characterised in that：The non-transitory storage medium further includes
Instructions for performing the following operations：
The first thresholding, the second thresholding, third thresholding, the first numerical value, second value and third number are determined by following operation
Value：
Collect the historical clinical information of dialysis machine brand message, dialyzate brand message and hospital where dialysis patient；
Historical clinical letter based on hospital where the collection dialysis machine brand message, dialyzate brand message and dialysis patient
Breath, determined using neural network algorithm first thresholding, the second thresholding, third thresholding, the first numerical value, second value and
Third value.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810193947.7A CN108355185B (en) | 2018-03-09 | 2018-03-09 | For monitoring the automation equipment and storage medium of concentration of glucose in dialyzate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810193947.7A CN108355185B (en) | 2018-03-09 | 2018-03-09 | For monitoring the automation equipment and storage medium of concentration of glucose in dialyzate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108355185A true CN108355185A (en) | 2018-08-03 |
| CN108355185B CN108355185B (en) | 2019-11-29 |
Family
ID=63003986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810193947.7A Expired - Fee Related CN108355185B (en) | 2018-03-09 | 2018-03-09 | For monitoring the automation equipment and storage medium of concentration of glucose in dialyzate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108355185B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101883521A (en) * | 2007-11-12 | 2010-11-10 | 费森尼斯医疗德国公司 | The device that is used to judge the method for at least one feature relevant and is used to carry out described method with the patient's glucose metabolism |
| CN103830792A (en) * | 2012-11-26 | 2014-06-04 | 贝克顿·迪金森公司 | Glucose management and dialysis method and apparatus |
| JP2017196394A (en) * | 2016-04-20 | 2017-11-02 | 日機装株式会社 | Dialysis system, sugar replenishing method, and sugar replenishing program |
-
2018
- 2018-03-09 CN CN201810193947.7A patent/CN108355185B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101883521A (en) * | 2007-11-12 | 2010-11-10 | 费森尼斯医疗德国公司 | The device that is used to judge the method for at least one feature relevant and is used to carry out described method with the patient's glucose metabolism |
| CN103830792A (en) * | 2012-11-26 | 2014-06-04 | 贝克顿·迪金森公司 | Glucose management and dialysis method and apparatus |
| JP2017196394A (en) * | 2016-04-20 | 2017-11-02 | 日機装株式会社 | Dialysis system, sugar replenishing method, and sugar replenishing program |
Non-Patent Citations (1)
| Title |
|---|
| 周健 等: "动态血糖评估参数正常参考值的建立", 《中华医学杂志》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108355185B (en) | 2019-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200245927A1 (en) | Precision dialysis monitoring and synchonization system | |
| US20220137025A1 (en) | End of life detection for analyte sensors | |
| US8246563B2 (en) | Cardiac rhythm management device and sensor-suite for the optimal control of ultrafiltration and renal replacement therapies | |
| WO2021034784A1 (en) | Device and method for medical diagnostics | |
| US20160085927A1 (en) | Dynamically adaptive care plans | |
| US11803769B2 (en) | End of life detection for analyte sensors experiencing progressive sensor decline | |
| US20240082472A1 (en) | Parameter Monitoring in Medical Treatment Systems | |
| EP3651645B1 (en) | Apparatus and method for determining interstitial fluid volume using bioimpendance information | |
| CN104688207A (en) | Healthy physical sign intelligent prompt method | |
| CN114616004A (en) | Dialysis system with continuous glucose monitoring | |
| CN113643820A (en) | Early warning information generation method and device, computer equipment and storage medium | |
| CN108355185B (en) | For monitoring the automation equipment and storage medium of concentration of glucose in dialyzate | |
| CN209529783U (en) | System for being determined after the dialysis of dry weight | |
| US20230018668A1 (en) | Hemodialysis treatment modification | |
| Cescon et al. | Subspace-based model identification of diabetic blood glucose dynamics | |
| EP3971905A1 (en) | System and method for blood glucose control | |
| CN115297910A (en) | Ultrafiltration control in extracorporeal blood treatment | |
| Kovács et al. | Physiological modeling and control at Obuda University | |
| CN115253062B (en) | Adaptability training method and device, electronic equipment and medium | |
| US20200375471A1 (en) | System and method for measuring pressure waves in dialysis lines | |
| Ardi et al. | Decision Tree for Predicting the Mortality in Hemodialysis Patient with Diabetes | |
| CN117379625A (en) | Liquid balance intelligent management system for peritoneal dialysis | |
| WO2022055990A1 (en) | Detection of changes in patient health based on peak and non-peak patient activity data | |
| KR20230090385A (en) | Artificial pancreas management systems and methods | |
| CN117377432A (en) | Dynamic and modular cardiac event detection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191129 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |